Disease-modifying therapies in multiple sclerosis in Latin America

The treatment of multiple sclerosis (MS) has become increasingly complex during the last 10 years, mainly because of the advent of new and more potent disease-modifying therapies (DMTs). In Latin America, the therapeutic repertoire available for MS treatment is similar to the one in the rest of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Skromne-Eisenberg, Eli, Ordoñez-Boschetti, Laura, Treviño-Frenk, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Special Issue: MS in Latin America
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617092/
https://www.ncbi.nlm.nih.gov/pubmed/28979794
http://dx.doi.org/10.1177/2055217317723369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617092/
https://www.ncbi.nlm.nih.gov/pubmed/28979794
http://dx.doi.org/10.1177/2055217317723369

Ejemplares similares